1.Hsu YN, Liu CJ, Lin JK, et al. Liver Abscess After Liver Metastasectomy is a PoorPrognostic Factor in Patients with Colorectal Cancer. Journal of Gastrointestinal Surgery(2011)15:1798–1806
2.YN Hsu, et al. A new classification scheme for recurrent or metastatic colon cancer after liver metastasectomy. Journal of Chinese Medical Association2011 Nov;74(11):493-9
3.Liu JH, Hsieh YY, Chen WS, Hsu YN, et al. Adjuvant oxaliplatin- or irinotecan-containing chemotherapyimproves overall survival following resectionof metachronous colorectal liver metastases. International Journal of Colorectal Disease (2010) 25:1243–1249
4.Hsieh YY, Hong YC, Hsiao LT, Yu YB, Liu JH, Gau JP, Lin HN, Hsu YN et al. Effect of allogeneic hematopoietic stem cell transplantation from matched siblings or unrelated donors during the first complete remission in patients with cytogenetically normal acute myeloid leukemia. European Journal of Haematology (2011) 86: 237–245
5.Yu-Hsien Chen, Tzeon-JyeChiou, Yen-Ning Hsu, Chun-Yu Liu. Idiopathic hyperammonemia after chemotherapy with vinorelbine, topotecan, and cisplatin in a patient with acute lymphocytic leukemia . Hematology/Oncology and stem cell therapy. 2010; 3(4): 199-202
6.Teng HW, Yang SH, Lin JK, Chen WS, Lin TC, Jiang JK, Yen CC, Li AF, Chen PC, Lan YT, Lin CC, Hsu YN, et al. CIP2A is a predictor of poor prognosis in colon cancer. Journal of Gastrointestinal Surgery 2012 May;16(5):1037-47
7.許彥寧, 鄧豪偉, 顏厥 大腸癌肝臟轉移的治療 臨床醫學 65:6=390 2010.06[民99.06]頁411-416
8.許彥寧, 高志平 Hepcidin：體內鐵質代謝的新調節者. 64:3=381 2009.09[民98.09]頁222-226
9.Yang CY, Chen BN, Chang KM, Hsu YN: Unusual presentation of lung adenocarcinoma with tonsil and colon metastases: a case report. Int J Clin Exp Med. 2018; 11(12):13864-13867